2024.08.08 UPDATE!!!!
Applications are open!!
Good luck to all applicants
Great opportunity for younger Genome Editing trainees and early career scientists: #ClinicalApplication Aarhus-GenEHumDi Course September 2024 is coming!
GeneHumdi chair Karim Benabdellah has confirmed the participation of the COST Action CA21113 in the incoming training school “Clinical Applications of In Vivo Gene Editing: Methods, Challenges, and Solutions” in collaboration with the Department
of Biomedicine, Aarhus University. It will be held 17th -20th September in Aarhus, Denmark.
The course will be locally organized by esteemed Dr. Yonglun Luo, and Dr. Karim Benabdellah, and will be coordinated by the European COST action “Genome Editing to Treat Human Diseases” (GenE-Humdi; action CA21113), an EU-funded network that connects researchers and innovators across Europe and beyond.
In this course, we investigate into the complex landscape of gene editing within a clinical framework, focusing on the generation of a comprehensive map detailing current delivery methodologies employed for in vivo gene editing across various animal models and clinical scenarios, with some insight for ex vivo studies. The course includes a meticulous comparison of efficacy and specificity data, elucidating the diverse array of gene editing tools administered through different delivery methods within specific tissues and organs of interest
Main Objectives:
1. To become familiar with CRISPR techniques: Participants will gain a thorough understanding of CRISPR technology, including its mechanisms, applications, and potential for genetic modification.
2. To learn about AAV (Adeno-Associated Virus) delivery systems: The course will cover the use of AAV vectors in gene editing, focusing on their design, delivery, especially as Donor template for Gene editing approaches as well for transient endonuclease delivery
3. To explore LNP (Lipid Nanoparticle) systems: Attendees will delve into the principles and applications of LNPs in gene editing, particularly their use in delivering mRNA and other gene editing tools
4. To understand the application of LVs (Lentiviral Vectors): The program will provide insights into the use of lentiviral vectors for gene editing.
5. case studies and practical examples of their use in treating different pathologies such as, cancer (Immunotherapy) Neuromuscular Disorders (NMDs), neurological disorders, and Retinal, Pancreatic, and Cardiac Diseases.
Check the full program bellow:
GenEHumDi has also launch an specific call to support Young Researchers and Students willing to expand their abilities attending to this Course. If you qualify to assist the course apply for a GeneHumDi support grant :
To qualify for support, APPLICANTS ARE URGED TO SEND A FILLED FORM IN ADVANCED (download the template form below) BEFORE AUGUST 24th
Good Luck to all applicants. We see each other in Aarhus!!
For more info on the Summer School Applications and COST support options, follow us GeneHumdi on the LinkedIn GeneHumdi Page, Twitter @genehumdi or our web updates at www.genehumdi.eu
